1 |
Ishikawa I, Nakashima K, Koseki T et al, Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000, 1997;14:79-111
DOI
ScienceOn
|
2 |
Sakata M, Shiba H, Komatsuzawa H et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. J Bone Miner Res 1999;14:1486-92
DOI
ScienceOn
|
3 |
Muhlemann HR and Son S. Gingival sulcus bleeding a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107
PUBMED
|
4 |
Kang MG, Cha HG, Song SH et al. MMP-2, MMP-8 Expression in gingival tissue of chronic periodontitis associated to Type 2 Diabetes Mellitus. Journal of Korean Academy of Periodontology 2005;35:661-674
|
5 |
Cho JY, Xing S, Liu X et al. Expression and activity of human Na+/I-symporterinhumangliomacellsbyadenovirus- mediatedg enedelivary. GeneTherapy 2000;7:740-749
PUBMED
|
6 |
Nagasawa T, Kobayashi H, Kiji M et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002; 130:338-44
DOI
|
7 |
Liu D, Xu JK, Figliomeni L et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003;11: 17-21
PUBMED
|
8 |
Belibasakis GN, Johansson A, Wang Y et al. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005;30:56-63
DOI
ScienceOn
|
9 |
Kawai T, Matsuyama T, Hosokawa Y et al. Band T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169:987-98
DOI
ScienceOn
|
10 |
Tsukii K, Shima N, Mochizuki S et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun. 1998;246:337-41
DOI
ScienceOn
|
11 |
Kikuchi T, Matsuguchi T, Tsuboi N et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001;166:3574-9
DOI
PUBMED
|
12 |
Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci U S A. 1998;95: 3597-602
DOI
|
13 |
Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-53
DOI
ScienceOn
|
14 |
Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma, Expression of membrane- bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004;94:239-46
DOI
ScienceOn
|
15 |
Amitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6
DOI
ScienceOn
|
16 |
Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-37
DOI
ScienceOn
|
17 |
Hormdee D, Nagasawa T, Kiji M. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Clin Exp Immunol 2005;142:490-7
|
18 |
Teng YT, Nguyen H, Gao X et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:R59-67
DOI
ScienceOn
|
19 |
Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1990;32:524-9
DOI
ScienceOn
|
20 |
Ogasawara T, Yoshimine Y, Kiyoshima T et al. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. J Periodontal Res 2004;39:42-9
DOI
ScienceOn
|
21 |
Hsu H, Lacey DL, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96:3540-5
DOI
|
22 |
Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59
DOI
ScienceOn
|
23 |
Nagasawa T, Kiji M, Yashiro R et al. Roles of receptor activator of nuclear factor- kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000. 2007;43:65-84. Review
DOI
ScienceOn
|
24 |
Theoleyre S, Wittrant Y, Tat SK et al. The molecular triad OPG/RANK/RANKL: in volvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004;15:457-75
DOI
ScienceOn
|
25 |
Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol 2001;28(9): 840-7
DOI
ScienceOn
|
26 |
Bostanci N, Ilgenli T, Emingil G et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007;42:287-93
DOI
ScienceOn
|
27 |
Quinn JMW, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation, J Bone Miner Res 2000;15(8): 1459-66
DOI
ScienceOn
|
28 |
Taubman MA, Kawai T, Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001;12:125-35
DOI
|
29 |
Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ. Prostaglandin E2 is a main mediator in receptor activator of nuclear factor-kB ligand- dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 2005;76:813-820
DOI
ScienceOn
|
30 |
Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25
DOI
ScienceOn
|
31 |
Huang JC, Sakata T, Pfleger LL et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004; 19:235-44
DOI
ScienceOn
|
32 |
Hofbauer LC, Khosla S, Dunstan CR et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12
DOI
ScienceOn
|
33 |
Okahashi N, Inaba H, Nakagawa I et al. Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway. Infect Immun 2004;72:1706-14
DOI
PUBMED
|
34 |
Bostanci N, Ilgenli T, Emingil G et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-6
DOI
ScienceOn
|
35 |
Mizuno N, Shiba H, Mouri Y et al. Characterization of epithelial cells derived from periodontal ligament by gene expression patterns of bone-related and enamel proteins. Cell Biol Int 2005;29:111-7
DOI
ScienceOn
|
36 |
Crotti T, Smith MD, Hirsch R et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-7
DOI
PUBMED
ScienceOn
|
37 |
Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-9
DOI
ScienceOn
|